benavis is developing and licensing highly sophisticated yet extremely affordable medicinal products, mainly in the field of anti-cancer medicines.

benavis has already consulted other companies in developing and registering generic and biosimilar products, and has now built the platform to serve the patients in a more direct way.

we are now able to bring newest generic and biosimilar products with highest quality, strictly following European GMP-standards, and lowest prices to countries and people who are often not reached by this advanced medication.